Page last updated: 2024-12-07

indenestrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Indenestrol is a synthetic nonsteroidal estrogen that was once used as a medication to treat menopausal symptoms and certain types of cancer. It was synthesized in the 1940s and gained popularity due to its potent estrogenic activity. Indenestrol has been shown to have a variety of effects, including stimulating the growth of the uterus and breasts, regulating the menstrual cycle, and reducing bone loss. However, its use has declined due to concerns about potential side effects, such as an increased risk of blood clots, stroke, and certain types of cancer. Research on indenestrol has focused on its potential applications in hormone replacement therapy and as an anti-cancer agent. Studies have explored its mechanism of action, its efficacy, and its safety profile. Despite its past clinical use, indenestrol is currently not approved for medical use in most countries due to concerns about its potential risks.'

Cross-References

ID SourceID
PubMed CID107664
CHEMBL ID412451
SCHEMBL ID8383765
MeSH IDM0136984

Synonyms (24)

Synonym
s-indenestrol a
indenestrol a
1h-inden-6-ol, 3-ethyl-2-(4-hydroxyphenyl)-1-methyl-
indenoestrol a
3-ethyl-2-(p-hydroxyphenyl)-1-methylinden-6-ol
inden-6-ol, 3-ethyl-2-(p-hydroxyphenyl)-1-methyl-
3-ethyl-2-(4-hydroxyphenyl)-1-methyl-1h-inden-6-ol
indenestrol
24643-97-8
CHEMBL412451
1-ethyl-2-(4-hydroxyphenyl)-3-methyl-3h-inden-5-ol
(+/-)-3-ethyl-2-(4-hydroxyphenyl)-1-methyl-1h-inden-6-ol
ccris 7694
(+-)-indenestrol a
115217-02-2
4a464k3bsi ,
unii-4a464k3bsi
(+/-)-indenestrol a
(rs)-indenestrol a
indenestrol-a, (+/-)-
indenestrol-a
SCHEMBL8383765
DTXSID30921653
Q27259327

Research Excerpts

Overview

Indenestrol A (IA) is a metabolite of diethylstilbestrol (DES), and indenESTrol B (IB) is an analog of IA.

ExcerptReferenceRelevance
"Indenestrol A (IA) is a metabolite of diethylstilbestrol (DES), and indenestrol B (IB) is an analog of IA. "( Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule polymerization.
Hanzawa, H; Hata, T; Oda, T; Sakakibara, Y; Sato, Y, 1992
)
2.01

Dosage Studied

ExcerptRelevanceReference
" Wild-type mER displayed similar dose-response curves for IA-R and demethyl IA, which lacks a C3 methyl group, demonstrating that the presence and correct orientation of the C3 methyl group on the IA compound is required for high-affinity ligand binding and transcriptional activity."( Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Bocchinfuso, WP; Curtis, SW; Gandini, O; Kohno, H; Korach, KS, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID69519Percent of relative binding affinity ( to that of estradiol) for estrogen receptor determined by competitive radiometric binding assay using [3H]estradiol as tracer in rat uterine cytosol1989Journal of medicinal chemistry, Sep, Volume: 32, Issue:9
2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (26.09)18.7374
1990's13 (56.52)18.2507
2000's4 (17.39)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.28 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]